Zero Gravity Solutions, Inc., (“ZGSI” or the “Company”) is an agricultural biotechnology public company commercializing its technology derived from and designed for Space with significant value and applications for agricultural markets on Earth. These technologies are focused on revolutionizing world agriculture by providing valuable solutions to major challenges facing humanity, including threats to world agriculture and the ability to feed the growing population. The two primary categories of the Company's technologies are:
1) a cost effective, ionic nutrient delivery system for plants that is designed to provide a way to achieve more robust, more productive crops while reducing chemical use, waterway contamination and irrigation and
2) the development and production, in the prolonged zero/micro gravity environment of the International Space Station (ISS), large volumes of NON-GMO, novel stem cells with unique and beneficial characteristics, which can be patented for commercial sale to third parties in the agricultural and human regenerative medical markets. ZGSI has two wholly-owned subsidiares operating its two core business interests, BAM Agricultural Solutions, Inc., Inc. and Zero Gravity Life Sciences, Inc.
The Company's technologies were originally created by ZGSI's co-founder and Chief Science Officer, John W. Kennedy, to promote growth of strong plants for NASA astronauts on long duration Space missions on the International Space Station and deep space voyages, such as to Mars, but have demonstrated significant applications to agriculture here on Earth. We are using our patented platform technologies to introduce a broad and evolving product line precision agriculture products directed toward providing solutions to critical world food crops challenges. Our commercially available product, BAM-FX™, is an ionic nutrient delivery system that can be used as a standalone product or in conjunction with other products, such as standard NPK fertilizers, pesticides and fungicides. BAM-FX is a more precise way to maximize crop plant mineral nutrition, which results in a more robust crop with greater yields. The ability to potentially create more robust plants could provide breakthrough commercial products and solve many of the problems facing world agriculture, including threats to crops, nutrient depletion in soil and agricultural run-off.
Additionally, through utilization of the unique long-term microgravity environment platform of the International Space Station, ZGSI aims to industrialize and commercialize scientific breakthroughs in the area of patentable stem cell technologies through developing advances in plant, animal and human biology. Based on intellectual property derived from multiple experiments on the ISS, the Company's Directed Selection™ technology is focused on developing and producing, in a microgravity environment and without introducing foreign genes (NON-GMO), large volumes of novel stem cells with unique and beneficial characteristics. In conjunction with our collaborators, NASA, the USDA and the University of Florida, we have, over the past six years, conducted scientific studies on six NASA enabled flights to the International Space Station. The proof of principle concept experiments aboard the ISS demonstrated the expected results of differential gene expression and provided very strong evidence that plant and animal stem cells exposed to prolonged microgravity in space can be endowed, through Directed Selection™, with new characteristics of great benefit to mankind. Further, experiments unequivocally demonstrated cell replication at an accelerated rate.
ZGSI will continue to introduce a growing pipeline of BAM-FX related products directed at sustainable and precision agriculture as well as further commercialization of its space-derived technology.